SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001193125-21-033193
Filing Date
2021-02-09
Accepted
2021-02-09 06:09:52
Documents
5

Document Format Files

Seq Description Document Type Size
1 F-3/A d88247df3a.htm F-3/A 358043
2 EX-23.1 d88247dex231.htm EX-23.1 4147
3 GRAPHIC g88247d0001_818392.jpg GRAPHIC 49429
4 GRAPHIC g88247g02q20.jpg GRAPHIC 33289
5 GRAPHIC g88247g25e73.jpg GRAPHIC 3285
  Complete submission text file 0001193125-21-033193.txt   482130
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-3/A | Act: 33 | File No.: 333-252575 | Film No.: 21603819
SIC: 2834 Pharmaceutical Preparations